July 2, 2012 Updated 1:42 p.m. A team from Covington & Burling in Washington represented the pharmaceutical giant GlaxoSmithKline LLC in a record-setting $3 billion criminal and civil settlement over drug misbranding. Deputy Attorney General James Cole announced the deal today at the U.S. Justice Department, calling it "unprecedented in both size and scope." No executive was charged today. See Link below for full story. The BLT: The Blog of Legal Times From the link: GlaxoSmithKline agreed to plead guilty to criminal charges in U.S. District Court for the District of Massachusetts and to pay $1 billion in criminal fines and forfeitures for the illegal marketing and promotion of the drugs Paxil and Wellbutrin. Officials said the company between 1998 and 2003 unlawfully promoted Paxil for treating depression in patients under the age of 18. The Food and Drug Administration has not approved that use of the drug, DOJ officials said. The officials said GlaxoSmithKline illegally promoted Wellbutrin for uses that included weight loss, substance abuse and sexual dysfunction. Any wonder why the GOP wants to reduce/eliminate regulations?